Efficacy and safety of oral sildenafil in cystic fibrosis childrenwith mild to moderate lung disease

S. Javad Sayedi (Mashhad, Islamic Republic of Iran), M. Reisi (Mashhad, Islamic Republic of Iran), M. Modaresi (Mashhad, Islamic Republic of Iran), Z. Aghaii (Mashhad, Islamic Republic of Iran), S. Mirlohi (Mashhad, Islamic Republic of Iran), H. Rafiemanesh (Mashhad, Islamic Republic of Iran), G. Azizi (Mashhad, Islamic Republic of Iran)

Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Session: Clinical monitoring and new therapies for cystic fibrosis
Session type: E-poster session
Number: 369
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Javad Sayedi (Mashhad, Islamic Republic of Iran), M. Reisi (Mashhad, Islamic Republic of Iran), M. Modaresi (Mashhad, Islamic Republic of Iran), Z. Aghaii (Mashhad, Islamic Republic of Iran), S. Mirlohi (Mashhad, Islamic Republic of Iran), H. Rafiemanesh (Mashhad, Islamic Republic of Iran), G. Azizi (Mashhad, Islamic Republic of Iran). Efficacy and safety of oral sildenafil in cystic fibrosis childrenwith mild to moderate lung disease. 369

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: